Abstract
The formation of 3-(4-hydroxy-1-naphthoxy)lactic acid (4-HO-NLA) from propranolol was investigated. Authentic 4-HO-NLA was synthesized from 4-methoxy-1-naphthol using methods previously used for preparation of naphthoxylactic acid (NLA). Cleavage of the 4-methyl ether was accomplished using iodotrimethylsilane in the presence of cyclopentene. After ip administration of propranolol-3,3-d2 (P-3,3-d2) (20 mg/kg) to rats, 4-HO-NLA-d2 was identified by GC-MS as a urinary metabolite. After administering pseudoracemic propranolol (S-P-d0/R-P-3,3-d2) ip to rats (20 mg/kg), parent ions of 4-HO-NLA-d0 and -d2 as methyl ester-trifluoroacetyl derivatives were monitored by GC-MS. 4-HO-NLA arose stereoselectively from S-propranolol (S/R ratio 2.6). After administering approximately equimolar quantities of 4-HO-P and P-3,3-d2 (10 mg/kg each, ip), only 4-HO-NLA-d2 arising from metabolism of P-3,3-d2 was observed by GC-MS indicating that 4-HO-P is probably not an important metabolic intermediate in vivo. In vitro experiments in the presence of the rat liver supernatant fraction performed with P-3,3-d2, NLA, and 4-HO-P showed that only NLA led to 4-HO-NLA. Incubation of NLA also produced two other hydroxylated NLA regioisomers. Incubation of 4-methoxypropanolol, a more lipophilic congener of 4-HO-P, produced no lactic acid metabolite in the presence of the rat liver supernatant fraction, indicating that poor lipophilicity is not the only deterrent to N-dealkylation of the side chain of 4-HO-P.(ABSTRACT TRUNCATED AT 250 WORDS)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|